Morpholine

Morpholine

SCHEMBL3295641

C1COCCN1.N#Cc1ccc(S(=O)O)cc1

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GAA P10253 1/20 0.35
CYP2C9 P11712 1/20 0.35
CA2 P00918 3/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA6 P23280 1/20 0.35
CA9 Q16790 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA1 P00915 2/20 0.34
AR P10275 1/20 0.34
CD274 Q9NZQ7 1/20 0.34
PRKDC P78527 2/20 0.33
MMP1 P03956 1/20 0.33
MMP13 P45452 1/20 0.33
MMP3 P08254 1/20 0.32
ENPP2 Q13822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824866 0.82 CA2 (0.50) CA2CA12CA3CA6CA9
SCHEMBL1584347 0.80 CA2 (0.48) CA2CA12CA3CA6CA9
SCHEMBL11326418 0.80 CA2 (0.48) CA2CA12CA3CA6CA9
Morpholine SCHEMBL27991007 0.75 CYP2A6 (0.61) MEN1KMT2AKDM4EGAACYP2C9
Morpholine SCHEMBL28295537 0.75 EGFR (0.38) MEN1KMT2AKDM4EGAACYP2C9
Morpholine SCHEMBL17501724 0.71 MEN1 (0.61) MEN1KMT2AKDM4EGAACYP2C9
Morpholine SCHEMBL10970259 0.71 MEN1 (0.61) MEN1KMT2AKDM4EGAACYP2C9
Sulfurous Acid SCHEMBL11600401 0.71 CA2 (0.57) CA2CA12CA3CA6CA9
Morpholine SCHEMBL27685879 0.69 MEN1 (0.65) MEN1KMT2AKDM4EGAACYP2C9
Morpholine SCHEMBL27799126 0.69 MEN1 (0.65) MEN1KMT2AKDM4EGAACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1668039-B1 ARYLSULFINATE SALTS IN PHOTOINITIATOR SYSTEMS FOR POLYMERIZATION REACTIONS 3M INNOVATIVE PROPERTIES CO (US) 2012-12-05 EP disclosed
US-7732633-B2 Arylsulfinate salts in photoinitiator systems for polymerization reactions 3M INNOVATIVE PROPERTIES COMPANY (US) 2010-06-08 US disclosed
US-20090203904-A1 ARYLSULFINATE SALTS IN PHOTOINITIATOR SYSTEMS FOR POLYMERIZATION REACTIONS 3M INNOVATIVE PROPERTIES COMPANY 2009-08-13 US disclosed
US-7541389-B2 Arylsulfinate salts in photoinitiator systems for polymerization reactions 3M INNOVATIVE PROPERTIES COMPANY (US) 2009-06-02 US disclosed
US-20070249749-A1 ARYSULFINATE SALTS IN PHOTOINITIATOR SYSTEMS FOR POLYMERIZATION REACTIONS KALGUTKAR RAJDEEP S 2007-10-25 US disclosed
US-7064152-B2 Arylsulfinate salts in photoinitiator systems for polymerization reactions 3M INNOVATIVE PROPERTIES COMPANY (US) 2006-06-20 US disclosed
US-20050070624-A1 Arylsulfinate salts in photoinitiator systems for polymerization reactions 3M INNOVATIVE PROPERTIES COMPANY 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203904-A1 ARYLSULFINATE SALTS IN PHOTOINITIATOR SYSTEMS FOR POLYMERIZATION REACTIONS TST, ARSA, MPST OPRD1 1827/4885MEN1 4708/4885KMT2A 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.